Hakeem Funding: How Much Did They Raise & Key Investors

How Much Did Hakeem Raise?
Funding & Key Investors

Hakeem has successfully secured a major strategic investment, bringing its total capital accumulation to $1.7M. This latest infusion of $1.7M underscores the growing market confidence in the company's ability to integrate artificial intelligence into the clinical environment. By leveraging this significant financial backing, Hakeem is positioned to accelerate its mission of transforming how healthcare professionals interact with complex medical data at the point of care.

The recent financing round reflects a broader trend of institutional interest in health-tech solutions that prioritize diagnostic precision and operational efficiency. As the company transitions into its next phase of enterprise-level expansion, this capital will serve as a critical catalyst for scaling its proprietary AI-powered decision support platform across global hospital networks and academic institutions.

What is Hakeem?

Hakeem

Software

Healthcare Software

Hakeem operates at the intersection of medical informatics and machine learning, providing a sophisticated platform designed to enhance evidence-based care. By synthesizing vast repositories of medical research into actionable insights, the company addresses the persistent challenge of diagnostic uncertainty. Its platform serves as a digital bridge for clinicians, offering cited summaries and structured clinical drafts that streamline workflows and ensure adherence to rigorous medical guidelines. In an era where information overload often hinders medical decision-making, Hakeem provides a necessary layer of cognitive support, effectively reducing the time required for research while simultaneously elevating the standard of patient outcomes.

How much funding has Hakeem raised?

Hakeem has raised a total of $1.6M across 1 funding round:

2026

Unspecified

$1.6M

Unspecified (2026): $1.7M with participation from Merak Capital and Sanabil 500

Key Investors in Hakeem

Merak Capital

Merak Capital is a prominent investment firm focused on technology as a key driver for growth in Saudi Arabia and the MENA region, specializing in breakthrough software and hardware.

Sanabil 500

Sanabil 500 is a collaborative investment initiative focused on accelerating early-stage startups with high growth potential through strategic capital and mentorship.

What's next for Hakeem?

With this major enterprise-level funding, Hakeem is poised to deepen its market penetration and refine its algorithmic capabilities. The strategic roadmap likely includes the expansion of its database to include more specialized medical domains and the integration of its software into existing electronic health record systems. By focusing on interoperability and user-centric design, the company aims to become an indispensable utility for healthcare providers worldwide. The infusion of capital will also support the scaling of its technical infrastructure, ensuring that the platform remains robust and responsive as it handles increasing volumes of clinical queries. As Hakeem continues to mature, its focus will shift toward long-term sustainability and the establishment of new benchmarks for AI-assisted clinical excellence.

See full Hakeem company page

See More Financial Insights